Kyowa Kirin secures FDA approval for Crysvita dosing update
Pharmaceutical Technology
Kyowa Kirin has received approval from the FDA for a dosing update to the Crysvita prescribing information, introducing a new option for adults with XLH.
pharminent
May 15, 2026 (Last updated: May 21, 2026)
Pharmaceutical Technology
Kyowa Kirin has received approval from the FDA for a dosing update to the Crysvita prescribing information, introducing a new option for adults with XLH.
